Joshua Sabari

Edward Garon is the Director of the Thoracic Oncology Program at the David Geffen School of Medicine at UCLA and Director of the Signal Transduction and Therapeutics Program at the Jonsson Comprehensive Cancer Center at UCLA. He earned a bachelor’s degree in biology at the Massachusetts Institute of Technology. His M.D. degree was from Washington University in St. Louis. He performed his internship and residency at the University of Chicago. After a chief residency at Cook County Hospital in Chicago, he was a fellow in hematology and oncology at UCLA. He has remained at UCLA ever since and is currently a Professor of Medicine. He also received a Master's degree in clinical investigation from UCLA. He has been the principal investigator of peer reviewed grants from various funding organizations including the National Institute of Health in the United States. His focus is on clinical research and biomarker development. He has served as the principal investigator on national and international phase I, II and III clinical trials, including trials that have led to the approval of multiple drugs and a companion diagnostic.

Dr. Sabari is an Assistant Professor of Medicine, Thoracic Medical Oncologist and member of the Phase I Experimental Therapeutics Group in the Department of Medical Oncology at New York University School of Medicine, NYU Langone Health Perlmutter Cancer Center. Dr. Sabari is the Medical Director for the inpatient Hematology and Oncology Service at NYU Langone Health. Dr. Sabari’s research focus includes targeted therapy drug development in non-small cell and small cell lung cancer.